Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

8:15 AM - 8:30 AM ET

AAPM Highlights
Speaker: Ford, Eric, PhD, FASTRO - University of Washington / Fred Hutch Cancer Center, Seattle, WA
8:30 AM - 8:45 AM ET

ASCO Highlights
Speaker: Ruiz-Garcia, Erika, MD - Instituto Nacional de Cancerologia, Mexico City, Mexico City
8:45 AM - 9:00 AM ET

ESTRO Highlights
Speaker: Jereczek-Fossa, Barbara, MD, PhD, Prof. - European Institute of Oncology and University of Milan, Milan, Lombardy
12:30 PM - 12:35 PM ET

1115 - Daily Intraoral Photobiomodulation, Severe Oral Mucositis, and Feeding Tube Placement during IMRT for Head and Neck Cancer
Speaker: Shah, Pratish, MD, MBA - St. Elizabeth Medical Center, Edgewood, KY
12:30 PM - 12:40 PM ET

243 - From Data to Dialogue: A Real-Time Digital Platform Accelerates Multidisciplinary Decisions in Bone Metastases
Speaker: Bedi, Manpreet, MD, MS - Cleveland Clinic Florida, Weston, FL
12:30 PM - 12:40 PM ET

249 - A Randomized Phase II Study of Enhanced AR Blockade with Enzalutamide In High-Risk Patients with Biochemical Relapse Undergoing Salvage Radiation: Final Results from RTOG 3506 (STEEL)
Speaker: Posadas, Edwin, MD - Cedars-Sinai Medical Center, Los Angeles, CA
12:30 PM - 12:39 PM ET

255 - The HYPCON Trial 2: A Phase II Randomized Study Evaluating Hypofractionated vs. Conventional Adjuvant Concurrent Chemoradiation in Head and Neck Malignancies
Speaker: Ramadas, Aarcha, MBBS - AIIMS New Delhi, New Delhi, Delhi
12:30 PM - 12:40 PM ET

260 - Depletion of Alzheimer's-Associated Presenilin-1 Enhances Radiosensitivity of Hepatocellular Carcinoma
Speaker: Jia, Min-qi, PhD - Peking University Cancer Hospital, Beijing, Beijing
12:30 PM - 12:40 PM ET

266 - Time-Dependent Solution to the Van Herk PTV Margin Formalism for Brain, Head-and-Neck, Thorax, Breast, Abdomen and Pelvis Sites via 33,000 Image Pairs
Speaker: Pogue, Joel, PhD - University of Alabama at Birmingham, Birmingham, AL
12:30 PM - 12:40 PM ET

273 - A Prospective, Randomized Controlled Study on the Time Window of Radiotherapy Combined with Targeted Therapy for Primary Tumor in Stage IV NSCLC
Speaker: Jin, Feng, BS - Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou
12:30 PM - 1:45 PM ET

Advances in Multimodal Therapy for Glioblastoma: From Phase I to Phase III Trials
Speaker: Pendyala, Praveen, MD - Cleveland Clinic Taussig Cancer Center, Cleveland, OH
12:30 PM - 1:45 PM ET

Advances in Multimodal Therapy for Glioblastoma: From Phase I to Phase III Trials
Speaker: Alonso-Basanta, Michelle, MD, PhD, FASTRO - University of Pennsylvania, Philadelphia, PA